source
- BioNTech appoints Guido Oelkers as new CEO, succeeding cofounder Ugur SahinBioNTech announced that Guido Oelkers will become its chief executive officer, taking over from cofounder Ugur Sahin. Oelkers comes from Swedish biopharma Sobi, where he led the company, and bring…
- Biotech leaders urge faster IND process as FDA launches TrialBlazer pilotThe U.S. Department of Health and Human Services has introduced Operation TrialBlazer, a pilot program aimed at simplifying the investigational new drug (IND) application and approval process. The…